An Act to amend 961.385 (2) (cs) 1., 961.385 (5) (b) and 961.385 (6) (a) of the statutes; Relating to: the prescription drug monitoring program. (FE)
| Date / House | Action | Journal |
|---|---|---|
| 11/22/2019 Sen. | Introduced by Senators Testin, Cowles, Olsen, Schachtner, Wanggaard and Marklein; cosponsored by Representatives Nygren, Plumer, Magnafici, Hutton, James, Petryk, Kolste, Sargent, Billings, Born, Bowen, Dittrich, Doyle, Duchow, Edming, Felzkowski, Jagler, Kitchens, Knodl, Kulp, Mursau, Petersen, Pope, Quinn, Ramthun, Rohrkaste, Snyder, Spiros, Spreitzer, Thiesfeldt, Tranel and Tusler | |
| 11/22/2019 Sen. | Read first time and referred to Committee on Health and Human Services | |
| 12/3/2019 Sen. | Fiscal estimate received | |
| 12/6/2019 Sen. | Representative Wichgers added as a cosponsor | |
| 1/6/2020 Sen. | Representative Stuck added as a cosponsor | |
| 1/8/2020 Sen. | Public hearing held | |
| 1/23/2020 Sen. | Executive action taken | |
| 1/23/2020 Sen. | Report passage recommended by Committee on Health and Human Services, Ayes 5, Noes 0 | |
| 1/23/2020 Sen. | Available for scheduling | |
| 2/19/2020 Sen. | Senator Larson added as a coauthor | |
| 4/1/2020 Sen. | Failed to pass pursuant to Senate Joint Resolution 1 |
